These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10942242)

  • 21. Groove- and sequence-selective alkylation of DNA by sulfonate esters tethered to lexitropsins.
    Zhang Y; Chen FX; Mehta P; Gold B
    Biochemistry; 1993 Aug; 32(31):7954-65. PubMed ID: 8394120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
    Liu L; Taverna P; Whitacre CM; Chatterjee S; Gerson SL
    Clin Cancer Res; 1999 Oct; 5(10):2908-17. PubMed ID: 10537360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influences of base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent.
    Monti P; Campomenosi P; Ciribilli Y; Iannone R; Inga A; Shah D; Scott G; Burns PA; Menichini P; Abbondandolo A; Gold B; Fronza G
    J Biol Chem; 2002 Aug; 277(32):28663-8. PubMed ID: 12042310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N3-methyladenine induces early poly(ADP-ribosylation), reduction of nuclear factor-kappa B DNA binding ability, and nuclear up-regulation of telomerase activity.
    Tentori L; Forini O; Fossile E; Muzi A; Vergati M; Portarena I; Amici C; Gold B; Graziani G
    Mol Pharmacol; 2005 Feb; 67(2):572-81. PubMed ID: 15548765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA damage and cytotoxicity induced by minor groove binding methyl sulfonate esters.
    Varadarajan S; Shah D; Dande P; Settles S; Chen FX; Fronza G; Gold B
    Biochemistry; 2003 Dec; 42(48):14318-27. PubMed ID: 14640700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.
    Tentori L; Orlando L; Lacal PM; Benincasa E; Faraoni I; Bonmassar E; D'Atri S; Graziani G
    Mol Pharmacol; 1997 Aug; 52(2):249-58. PubMed ID: 9271347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substrate binding pocket residues of human alkyladenine-DNA glycosylase critical for methylating agent survival.
    Chen CY; Guo HH; Shah D; Blank A; Samson LD; Loeb LA
    DNA Repair (Amst); 2008 Oct; 7(10):1731-45. PubMed ID: 18706524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of nucleotide- and base-excision repair in genotoxin-induced neuronal cell death.
    Kisby GE; Lesselroth H; Olivas A; Samson L; Gold B; Tanaka K; Turker MS
    DNA Repair (Amst); 2004 Jun; 3(6):617-27. PubMed ID: 15135729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A chemical and genetic approach together define the biological consequences of 3-methyladenine lesions in the mammalian genome.
    Engelward BP; Allan JM; Dreslin AJ; Kelly JD; Wu MM; Gold B; Samson LD
    J Biol Chem; 1998 Feb; 273(9):5412-8. PubMed ID: 9479003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-ray repair cross-complementing gene I protein plays an important role in camptothecin resistance.
    Park SY; Lam W; Cheng YC
    Cancer Res; 2002 Jan; 62(2):459-65. PubMed ID: 11809696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.
    Wedge SR; Porteous JK; Newlands ES
    Br J Cancer; 1996 Oct; 74(7):1030-6. PubMed ID: 8855970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cells.
    Chen WD; Eshleman JR; Aminoshariae MR; Ma AH; Veloso N; Markowitz SD; Sedwick WD; Veigl ML
    J Natl Cancer Inst; 2000 Mar; 92(6):480-5. PubMed ID: 10716966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypersensitivity of DNA polymerase beta null mouse fibroblasts reflects accumulation of cytotoxic repair intermediates from site-specific alkyl DNA lesions.
    Horton JK; Joyce-Gray DF; Pachkowski BF; Swenberg JA; Wilson SH
    DNA Repair (Amst); 2003 Jan; 2(1):27-48. PubMed ID: 12509266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the mismatch repair system in temozolomide-induced apoptosis.
    D'Atri S; Tentori L; Lacal PM; Graziani G; Pagani E; Benincasa E; Zambruno G; Bonmassar E; Jiricny J
    Mol Pharmacol; 1998 Aug; 54(2):334-41. PubMed ID: 9687575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents.
    Colella G; Marchini S; D'Incalci M; Brown R; Broggini M
    Br J Cancer; 1999 May; 80(3-4):338-43. PubMed ID: 10408835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
    Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Werner syndrome protein confers resistance to the DNA lesions N3-methyladenine and O6-methylguanine: implications for WRN function.
    Blank A; Bobola MS; Gold B; Varadarajan S; D Kolstoe D; Meade EH; Rabinovitch PS; Loeb LA; Silber JR
    DNA Repair (Amst); 2004 Jun; 3(6):629-38. PubMed ID: 15135730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ADP-ribose) polymerase-independent potentiation of nitrosourea cytotoxicity by 3-aminobenzamide in human malignant glioma cells.
    Winter S; Weller M
    Eur J Pharmacol; 2000 Jun; 398(2):177-83. PubMed ID: 10854828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenicity of N3-methyladenine: a multi-translesion polymerase affair.
    Monti P; Traverso I; Casolari L; Menichini P; Inga A; Ottaggio L; Russo D; Iyer P; Gold B; Fronza G
    Mutat Res; 2010 Jan; 683(1-2):50-6. PubMed ID: 19874831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
    Humbert O; Fiumicino S; Aquilina G; Branch P; Oda S; Zijno A; Karran P; Bignami M
    Carcinogenesis; 1999 Feb; 20(2):205-14. PubMed ID: 10069455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.